Phase II Clinical Trial – CFN Media

Healthcare Stocks

Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

Topline Results Expected in Q2 2024 This is a Designated News Release.…

Ryan Allway
February 21, 2024

Tryp Therapeutics Announces Interim Results for Its Phase II Clinical Trial for the Treatment of Binge Eating Disorder With Psilocybin-Assisted Psychotherapy

Interim data analysis supports the potential effectiveness of psilocybin-assisted psychotherapy for the…

Ryan Allway
January 5, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

New Plastic Recycling Tech Hits the NASDAQ

Plastic recycling is woefully broken. Despite decades of public encouragement of…

Robin Lefferts
November 7, 2024

How to Invest in the LFP Electric Battery Boom

All electric cars, whether fully electric or hybrid, need some form of…

Robin Lefferts
November 6, 2024

Top News

Introducing LEEF Brands, Vertically Integrated California Powerhouse

The cannabis industry has fallen out of favor with many investors, in…

Ryan Allway
November 1, 2024

Aduro Clean Technologies Reports Fiscal 2025 First Quarter Results

LONDON, Ontario, Oct. 31, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies…

Ryan Allway
October 31, 2024